Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold

Henrik Johansson; Michael Worch Boesgaard; Lenea Nørskov-Lauritsen; Inna Larsen; Sebastiaan Kuhne; David E Gloriam; Hans Bräuner-Osborne; Daniel Sejer Pedersen

doi:10.1021/acs.jmedchem.5b01254

Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold

Henrik Johansson, Michael Worch Boesgaard, Lenea Nørskov-Lauritsen, Inna Larsen, Sebastiaan Kuhne, David E Gloriam, Hans Bräuner-Osborne, Daniel Sejer Pedersen

LUKKET: Institut for Lægemiddeldesign og Farmakologi

16 Citationer (Scopus)

Abstract

G protein-coupled receptors (GPCRs) represent a biological target class of fundamental importance in drug therapy. The GPRC6A receptor is a newly deorphanized class C GPCR that we recently reported for the first allosteric antagonists based on the 2-arylindole privileged structure scaffold (e.g., 1-3). Herein, we present the first structure-activity relationship study for the 2-arylindole antagonist 3, comprising the design, synthesis, and pharmacological evaluation of a focused library of 3-substituted 2-arylindoles. In a FRET-based inositol monophosphate (IP1) assay we identified compounds 7, 13e, and 34b as antagonists at the GPRC6A receptor in the low micromolar range and show that 7 and 34b display >9-fold selectivity for the GPRC6A receptor over related GPCRs, making 7 and 34b the most potent and selective antagonists for the GPRC6A receptor reported to date.

Originalsprog	Engelsk
Tidsskrift	Journal of Medicinal Chemistry
Vol/bind	58
Udgave nummer	22
Sider (fra-til)	8938-51
Antal sider	14
ISSN	0022-2623
DOI	https://doi.org/10.1021/acs.jmedchem.5b01254
Status	Udgivet - 25 nov. 2015

Adgang til dokumentet

10.1021/acs.jmedchem.5b01254

Citationsformater

Johansson, H., Boesgaard, M. W., Nørskov-Lauritsen, L., Larsen, I., Kuhne, S., Gloriam, D. E., Bräuner-Osborne, H., & Sejer Pedersen, D. (2015). Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold. Journal of Medicinal Chemistry, 58(22), 8938-51. https://doi.org/10.1021/acs.jmedchem.5b01254

Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold. / Johansson, Henrik; Boesgaard, Michael Worch; Nørskov-Lauritsen, Lenea et al.

I: Journal of Medicinal Chemistry, Bind 58, Nr. 22, 25.11.2015, s. 8938-51.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Johansson, H, Boesgaard, MW, Nørskov-Lauritsen, L, Larsen, I, Kuhne, S, Gloriam, DE , Bräuner-Osborne, H & Sejer Pedersen, D 2015, 'Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold', Journal of Medicinal Chemistry, bind 58, nr. 22, s. 8938-51. https://doi.org/10.1021/acs.jmedchem.5b01254

@article{ef12bbcc8de742fcbd3192cb54ceaa16,

title = "Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold",

abstract = "G protein-coupled receptors (GPCRs) represent a biological target class of fundamental importance in drug therapy. The GPRC6A receptor is a newly deorphanized class C GPCR that we recently reported for the first allosteric antagonists based on the 2-arylindole privileged structure scaffold (e.g., 1-3). Herein, we present the first structure-activity relationship study for the 2-arylindole antagonist 3, comprising the design, synthesis, and pharmacological evaluation of a focused library of 3-substituted 2-arylindoles. In a FRET-based inositol monophosphate (IP1) assay we identified compounds 7, 13e, and 34b as antagonists at the GPRC6A receptor in the low micromolar range and show that 7 and 34b display >9-fold selectivity for the GPRC6A receptor over related GPCRs, making 7 and 34b the most potent and selective antagonists for the GPRC6A receptor reported to date.",

author = "Henrik Johansson and Boesgaard, {Michael Worch} and Lenea N{\o}rskov-Lauritsen and Inna Larsen and Sebastiaan Kuhne and Gloriam, {David E} and Hans Br{\"a}uner-Osborne and {Sejer Pedersen}, Daniel",

year = "2015",

month = nov,

day = "25",

doi = "10.1021/acs.jmedchem.5b01254",

language = "English",

volume = "58",

pages = "8938--51",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "22",

}

TY - JOUR

T1 - Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold

AU - Johansson, Henrik

AU - Boesgaard, Michael Worch

AU - Nørskov-Lauritsen, Lenea

AU - Larsen, Inna

AU - Kuhne, Sebastiaan

AU - Gloriam, David E

AU - Bräuner-Osborne, Hans

AU - Sejer Pedersen, Daniel

PY - 2015/11/25

Y1 - 2015/11/25

N2 - G protein-coupled receptors (GPCRs) represent a biological target class of fundamental importance in drug therapy. The GPRC6A receptor is a newly deorphanized class C GPCR that we recently reported for the first allosteric antagonists based on the 2-arylindole privileged structure scaffold (e.g., 1-3). Herein, we present the first structure-activity relationship study for the 2-arylindole antagonist 3, comprising the design, synthesis, and pharmacological evaluation of a focused library of 3-substituted 2-arylindoles. In a FRET-based inositol monophosphate (IP1) assay we identified compounds 7, 13e, and 34b as antagonists at the GPRC6A receptor in the low micromolar range and show that 7 and 34b display >9-fold selectivity for the GPRC6A receptor over related GPCRs, making 7 and 34b the most potent and selective antagonists for the GPRC6A receptor reported to date.

AB - G protein-coupled receptors (GPCRs) represent a biological target class of fundamental importance in drug therapy. The GPRC6A receptor is a newly deorphanized class C GPCR that we recently reported for the first allosteric antagonists based on the 2-arylindole privileged structure scaffold (e.g., 1-3). Herein, we present the first structure-activity relationship study for the 2-arylindole antagonist 3, comprising the design, synthesis, and pharmacological evaluation of a focused library of 3-substituted 2-arylindoles. In a FRET-based inositol monophosphate (IP1) assay we identified compounds 7, 13e, and 34b as antagonists at the GPRC6A receptor in the low micromolar range and show that 7 and 34b display >9-fold selectivity for the GPRC6A receptor over related GPCRs, making 7 and 34b the most potent and selective antagonists for the GPRC6A receptor reported to date.

U2 - 10.1021/acs.jmedchem.5b01254

DO - 10.1021/acs.jmedchem.5b01254

M3 - Journal article

C2 - 26516782

SN - 0022-2623

VL - 58

SP - 8938

EP - 8951

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 22

ER -

Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater